Edition:
United Kingdom

VistaGen Therapeutics Inc (VTGN.OQ)

VTGN.OQ on NASDAQ Stock Exchange Capital Market

1.19USD
22 Feb 2018
Change (% chg)

$0.02 (+1.71%)
Prev Close
$1.17
Open
$1.18
Day's High
$1.19
Day's Low
$1.15
Volume
14,948
Avg. Vol
250,019
52-wk High
$2.75
52-wk Low
$0.69

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec 0.00 -0.250
Sep 0.00 -0.531
Jun 0.00 -0.278
FY 2017 Mar '17 0.00 -0.325
Dec 1.25 -0.343
Sep 0.00 -0.416
Jun 0.00 -0.514
FY 2016 Mar '16 0.00 -4.445
Dec 0.00 -1.952
Sep 0.00 -5.263
Jun 0.00 -19.233
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Mar-18 1 0.00 0.00 0.00 0.00
Year Ending Mar-19 1 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Mar-18 1 -0.55 -0.55 -0.55 -0.50
Year Ending Mar-18 1 -2.08 -2.08 -2.08 -2.05
Year Ending Mar-19 1 -1.89 -1.89 -1.89 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.10 32.90
P/E High - Last 5 Yrs. -- 40.92 45.97
P/E Low - Last 5 Yrs. -- 23.79 24.37
Beta -0.57 0.90 0.89
Price to Sales (TTM) 13.68 3.98 5.77
Price to Book (MRQ) -- 4.84 5.41
Price to Tangible Book (MRQ) -- 5.66 6.98
Price to Cash Flow (TTM) -- 23.02 23.42
% Owned Institutions 18.15 1.25 2.22

Dividends

  Company industry sector
Dividend Yield -- 1.57 1.50
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.33 5.21
Payout Ratio(TTM) -- 45.86 43.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 3.67 9.24
Sales (TTM) vs TTM 1 Yr. Ago -- 4.72 5.59
Sales - 5 Yr. Growth Rate -1.41 10.02 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 45.84 16.64 19.65
EPS (TTM) vs TTM 1 Yr. Ago 88.82 -- --
EPS - 5 Yr. Growth Rate -- 9.82 10.73
Capital Spending - 5 Yr. Growth Rate 49.14 15.22 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) 2.12 2.89 2.97
LT Debt to Equity (MRQ) -- 9.91 12.22
Total Debt to Equity (MRQ) -- 13.93 16.52
Interest Coverage (TTM) -5,804.00 36.27 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.11 54.70
Gross Margin - 5 Yr. Avg. -- 52.40 52.42
EBITD Margin (TTM) -838.44 -- --
EBITD - 5 Yr. Avg -3,202.01 18.51 10.86
Operating Margin (TTM) -843.66 14.36 4.64
Operating Margin - 5 Yr. Avg. -5,471.17 14.42 6.26
Pre-Tax Margin (TTM) -844.10 14.77 5.44
Pre-Tax Margin - 5 Yr. Avg. -6,012.32 14.73 6.60
Net Profit Margin (TTM) -844.30 11.05 1.76
Net Profit Margin - 5 Yr. Avg. -6,013.25 11.07 2.91
Effective Tax Rate (TTM) -- 23.16 23.04
Effective Tax Rate - 5 Yr. Avg. -- 23.41 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 948,737,942 855,668,157
Net Income/Employee (TTM) -- 111,622,123 100,655,595
Receivable Turnover (TTM) -- 5.62 5.78
Inventory Turnover (TTM) -- 2.58 3.35
Asset Turnover (TTM) 0.22 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -188.55 11.45 10.98
Return on Assets - 5 Yr. Avg. -1,968.05 12.98 12.37
Return on Investment (TTM) -245.77 14.90 14.43
Return on Investment - 5 Yr. Avg. -- 16.98 16.18
Return on Equity (TTM) -415.24 16.41 16.13
Return on Equity - 5 Yr. Avg. -- 18.08 17.47
  1 Year 3 Year 5 Year
Sales % -- -- -1.41
EPS (TTM) % 94.69 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for VistaGen Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 24.69%
# of Holders: 18
Total Shares Held: 5,654,380
3 Mo. Net Change: 3,193,821
# New Positions: 6
# Closed Positions: 3
# Increased Positions: 10
# Reduced Positions: 4
# Net Buyers: 6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.